Istituto di Ricovero e Cura a Carattere Scientifico MultiMedica, Milan, Italy.
Istituto per l'Endocrinologia e l'Oncologia Sperimentale, Consiglio Nazionale delle Ricerche, Naples, Italy.
J Exp Med. 2021 May 3;218(5). doi: 10.1084/jem.20191593.
The discovery of the archetypal adipocytokine leptin and how it regulates energy homeostasis have represented breakthroughs in our understanding of the endocrine function of the adipose tissue and the biological determinants of human obesity. Investigations on leptin have also been instrumental in identifying physio-pathological connections between metabolic regulation and multiple immunological functions. For example, the description of the promoting activities of leptin on inflammation and cell proliferation have recognized the detrimental effects of leptin in connecting dysmetabolic conditions with cancer and with onset and/or progression of autoimmune disease. Here we review the multiple biological functions and complex framework of operations of leptin, discussing why and how the pleiotropic activities of this adipocytokine still pose major hurdles in the development of effective leptin-based therapeutic opportunities for different clinical conditions.
瘦素的发现及其对能量稳态的调节作用代表了我们对脂肪组织内分泌功能和人类肥胖生物学决定因素的理解的突破。对瘦素的研究也有助于确定代谢调节和多种免疫功能之间的生理病理联系。例如,瘦素促进炎症和细胞增殖的作用的描述,认识到瘦素在将代谢紊乱与癌症以及自身免疫性疾病的发生和/或进展联系起来的有害作用。在这里,我们回顾了瘦素的多种生物学功能和复杂的作用机制,讨论了为什么这种脂肪细胞因子的多效性活动仍然是开发针对不同临床情况的有效基于瘦素的治疗机会的主要障碍。